Caliber Imaging & Diagnostics (OTCMKTS:LCDX – Get Free Report) and Inogen (NASDAQ:INGN – Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, dividends, valuation and earnings.
Profitability
This table compares Caliber Imaging & Diagnostics and Inogen’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Caliber Imaging & Diagnostics | N/A | N/A | N/A |
Inogen | -28.30% | -45.37% | -28.57% |
Analyst Recommendations
This is a summary of recent ratings for Caliber Imaging & Diagnostics and Inogen, as reported by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Caliber Imaging & Diagnostics | 0 | 0 | 0 | 0 | N/A |
Inogen | 1 | 2 | 1 | 0 | 2.00 |
Insider & Institutional Ownership
89.9% of Inogen shares are held by institutional investors. 1.0% of Inogen shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Earnings & Valuation
This table compares Caliber Imaging & Diagnostics and Inogen’s top-line revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Caliber Imaging & Diagnostics | N/A | N/A | N/A | ($0.75) | 0.00 |
Inogen | $326.65 million | 0.82 | -$102.45 million | ($4.15) | -2.72 |
Caliber Imaging & Diagnostics has higher earnings, but lower revenue than Inogen. Inogen is trading at a lower price-to-earnings ratio than Caliber Imaging & Diagnostics, indicating that it is currently the more affordable of the two stocks.
About Caliber Imaging & Diagnostics
Caliber Imaging & Diagnostics, Inc., a medical technologies company, designs, develops, and markets imaging solutions that shows tissue at the cellular level in the United States. The company provides VivaScope 1500, a reflectance confocal imaging system that enables clinicians and researchers to capture confocal images that depict cellular structures of living tissue; and VivaScope 3000, a hand-held in vivo reflectance confocal microscope for skin imaging. It also offers VivaScan software to schedule patients for examinations, perform imaging examinations on one or more lesions during a visit, review, and report on images obtained during an examination, as well as VivaNet, a digital telepathology system. The company was formerly known as Lucid, Inc. and changed its name to Caliber Imaging & Diagnostics, Inc. in August 2012. Caliber Imaging & Diagnostics, Inc. was founded in 1991 and is headquartered in Andover, Massachusetts.
About Inogen
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
Receive News & Ratings for Caliber Imaging & Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Caliber Imaging & Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.